Additionally, STAT3 was found to associate with the SERT promoter in an IL-6-dependent manner, with the inhibition of STAT3 blocking the effect of IL-6 on 5-HT uptake in vitro and reducing depression-like behavior in vivo [133]. Here, SLC6A4 is linked to depressive symptom measurement.